Table 1 Clinical features of patients (n = 45)

Age(years), mean ± SD

57.92 ± 12.73

57.32 ± 10.09

0.863

Gender,n(%)

1.000

 Male

24

92.31%

17

89.47%

 Female

2

7.69%

2

10.53%

Hepatitis virus status, n (%)

0.029

 HBsAg ( +)

25

96.15%

14

73.68%

 HBsAg (-)

1

3.85%

5

26.32%

ALT (IU/L), n (%)

0.138

  > 40

12

46.15

13

68.42%

  ≤ 40

14

53.85%

6

31.58%

AST (IU/L), n (%)

0.463

  > 35

15

57.69%

13

68.42%

  ≤ 35

11

42.31%

6

31.58%

CEA(ng/ml)

0.365

  > 5

4

15.38%

5

26.32%

  ≤ 5

22

84.62%

14

73.68%

CA19-9(U/ml)

0.467

  > 27

8

30.77%

4

21.05%

  ≤ 27

18

69.23%

15

78.95%

CA125(U/ml)

0.103

  > 35

6

23.08%

1

5.26%

  ≤ 35

20

76.9%

18

94.74%

AFP(ng/ml)

0.033

  > 400

12

46.15%

3

15.79%

  ≤ 400

14

53.85%

16

84.21%

Vascular invasion, n (%)

0.006

 No

15

57.69%

18

94.74%

 Yes

11

42.31%

1

5.26%

Differentiation,n (%)

0.063

 Well or moderately

17

65.38%

17

89.47%

 Poorly

9

34.62%

2

10.53%

TNM Stage,n (%)

0.021

 I

15

57.69%

18

94.74%

 II

10

38.46%

1

5.26%

 III, IV

1

3.85%

0

0%

Recurrence

0.036

 Yes

19

73.08%

8

42.11%

 No

7

26.92%

11

57.89%